Endometrial Neoplasms: all 1,347 studies

Page 8 of 14. Open to participants first (452), then studies with results posted, then the rest; newest registration first within each.

• A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsActive, not recruitingNCT05787587Phase 1
• Developing a MRI-based Deep Learning Model to Predict MMR StatusStatus unknownNCT05783986
• Pilot: Intraoperative TAP Block and Post-operative Pain Control for Minimally Invasive Hysterectomy for Endometrial CancerCompletedNCT05763667Phase 3
• Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial CancerActive, not recruitingNCT05761951Phase 2
• Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)Active, not recruitingNCT05743517Not applicable
• Efficacy of PENS of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium and Cancer Cervix PatientsCompletedNCT05742711Not applicable
• Endometrial Changes in Breast Cancer Women.Status unknownNCT05717634
• Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial CancerWithdrawnNCT05712941Phase 3
• Staging Endometrial caNcer Based on molEcular ClAssificationStatus unknownNCT05707312
• Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial CancersActive, not recruitingNCT05691504Phase 1
• Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical CancerCompletedNCT05682950Phase 2
• Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) InterventionActive, not recruitingNCT05677048Not applicable
• TAS-116 Plus Palbociclib in Breast and Rb-null CancerWithdrawnNCT05655598Phase 1
• Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial CancerCompletedNCT05651282Phase 4
• An Observational Study Based on Endometrial Cancer Risk Screening ModelStatus unknownNCT05634798
• A Study of Giredestrant in Participants With Grade 1 Endometrial CancerCompletedNCT05634499Phase 2
• the Value of Immunohistochemical Expression of Moesin in Endometrial Hyperplasia and Endometrial CarcinomaStatus unknownNCT05619159
• Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial CarcinomaActive, not recruitingNCT05611931Phase 3
• Genetic Testing in African AmericansActive, not recruitingNCT05591131Not applicable
• Endometrial Lesions PredictionsStatus unknownNCT05588076
• Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment TrialActive, not recruitingNCT05554328Phase 2
• P53 Immunohistochemistry Abnormal Staining in Endometrial CancerCompletedNCT05542940
• A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid TumorsCompletedNCT05538572Phase 1
• Prolonged Grief and Perception of Femininity in Gynecological Cancer PatientsCompletedNCT05529303Not applicable
• First in Human Study of IMGN151 in Recurrent Gynaecological CancersActive, not recruitingNCT05527184Phase 1
• Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)Active, not recruitingNCT05520099
• Guangzhou Women's Health Cohort Study (GWHCS)SuspendedNCT05506800
• Detection of Tumor DNA Through Cervical Smear and Liquid Biopsy in Endometrial Cancer Patients and Evaluation of Prognostic and Predictive Values of Tumor DNA AssayStatus unknownNCT05504161
• 18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone TherapyWithdrawnNCT05483023Phase 2
• Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsActive, not recruitingNCT05462717Phase 1
• Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMPTerminatedNCT05454358Phase 2/3
• Opioid Free Anaesthesia in Oncologic Gynaecological Surgery: Is There Any Benefit?CompletedNCT05448586
• Pembrolizumab With Sitravatinib in Recurrent Endometrial Cancer and Other Solid Tumors With Deficient Mismatch Repair SystemWithdrawnNCT05419817Phase 2
• Targeting Inflammation for Endometrial Cancer PreventionActive, not recruitingNCT05407025
• Bariatric Education for Women With Obesity and Endometrial CancerTerminatedNCT05396794
• Radiomics Based Multimodal Transvaginal Ultrasound Imaging in Endometrial CancerStatus unknownNCT05387460
• Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1CompletedNCT05383482Phase 1/2
• Assessing the Benefit of Pipelle Biopsy in Patients With Postmenopausal Bleeding and an Atrophic-appearing CavityCompletedNCT05378152Not applicable
• A Study of Lenvatinib in Combination With Pembrolizumab in Korean PatientsCompletedNCT05375136
• Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial CarcinomaCompletedNCT05364905
• The Impact of Epigenetic MMRd in Endometrial carcinomas-a Real World StudyStatus unknownNCT05334303
• Study of Megestrol Acetate in Grade 2 Endometrioid Endometrial CancerTerminatedNCT05332483Phase 1
• Effects of PARP Inhibitor on Tumor Microenvironment in High-risk Endometrial Cancer PatientsCompletedNCT05320757Early Phase 1
• Weight Management Plus Megestrol Acetate in Early-stage Endometrioid CarcinomaTerminatedNCT05316467Phase 2/3
• DNA CDO1 and CELF4 Methylation for Endometrial Cancer ScreeningStatus unknownNCT05290922
• Host DNA Methylation for Endometrial Cancer ScreeningStatus unknownNCT05290415
• Niraparib in High-grade Endometrial Cancer TrialWithdrawnNCT05289648Early Phase 1
• Evaluation of MCM5 in Postmenopausal Bleeding PatientsStatus unknownNCT05287048
• First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid TumorsActive, not recruitingNCT05277051Phase 1
• A Study to Investigate LYL797 in Adults With Solid TumorsTerminatedNCT05274451Phase 1
• Molecular Biomarkers Predicting Early Development of Endometrial CarcinomaStatus unknownNCT05273099
• Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial CancerCompletedNCT05261165
• Frequency of Endometrial Cancer Precursors Associated with Lynch SyndromeCompletedNCT05257057
• Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or CarcinosarcomaActive, not recruitingNCT05256225Phase 3
• (VELA) Study of BLU-222 in Advanced Solid TumorsTerminatedNCT05252416Phase 1
• Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial CancerActive, not recruitingNCT05247268Phase 2
• The Effect of Logotherapy on Mental Health in Gynecological Cancer PatientsCompletedNCT05246462Not applicable
• Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal AtrophyCompletedNCT05243823
• FitEx for Endometrial Cancer SurvivorsCompletedNCT05233059Not applicable
• A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.CompletedNCT05230186
• A Study of SGN-ALPV in Advanced Solid TumorsTerminatedNCT05229900Phase 1
• Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological CancerActive, not recruitingNCT05220033Not applicable
• Optimising Cardiovascular Health in Endometrial Cancer SurvivorsActive, not recruitingNCT05216913
• Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First LineActive, not recruitingNCT05201547Phase 3
• A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsTerminatedNCT05194072Phase 1
• Endometrial Cancer Recurrence in Patients Taking MetforminWithdrawnNCT05192850
• Real-time Lymphatic Channel Visualization Improves Bilateral Sentinel Lymph Node Detection in Endometrial CancerCompletedNCT05191212Not applicable
• GEN1047 for Solid Tumors - First in Human (FIH) TrialTerminatedNCT05180474Phase 1/2
• Tempus Priority Study: A Pan-tumor Observational StudyActive, not recruitingNCT05179824
• Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)Active, not recruitingNCT05173987Phase 3
• The Effect of Androgen Receptor Polymorphism on Endometrial CancerStatus unknownNCT05157373
• A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid TumorsActive, not recruitingNCT05143970Phase 1
• HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid TumorsTerminatedNCT05124743
• A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial CarcinomaStatus unknownNCT05121363Phase 2
• A Study of DeTIL-0255 in Adults With Advanced MalignanciesTerminatedNCT05107739Phase 1
• Asian Multicenter Prospective Study of ctDNA SequencingActive, not recruitingNCT05099978
• Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IOActive, not recruitingNCT05078047Phase 3
• A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursActive, not recruitingNCT05057013Phase 1/2
• Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer PatientsStatus unknownNCT05056259
• Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)Active, not recruitingNCT05056077Not applicable
• Sentinel Lymph Node Biopsy Versus Lymphadenectomy in Endometrial CancerCompletedNCT05048173
• The LYSA (Linking You to Support and Advice) TrialCompletedNCT05035173Not applicable
• A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary MalignanciesActive, not recruitingNCT05032040Phase 2
• Vibrational Spectroscopy for Endometrial Cancer DiagnosisStatus unknownNCT05026073
• Adipocytokines in Endometrial CancerStatus unknownNCT05018195Not applicable
• A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)TerminatedNCT05001282Phase 1/2
• A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH )Status unknownNCT04998760Phase 2
• Effect of Pelvic Radiotherapy on the Intestinal Microbiome and MetabolomeCompletedNCT04995809
• Risk Assessment of Endometrial Hyperplasia and Endometrial CancerStatus unknownNCT04995731
• [SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial CancerCompletedNCT04972682Not applicable
• Comparison of Nodal Staging in Endometrial CancerTerminatedNCT04970368Phase 3
• A Prospective Multi-center Study on Using Sonazoid Diagnose Early Stage Endometrial CancerStatus unknownNCT04961775
• Pelvic Sentinel Node Detection Using Indocyanine Green Learning CurveStatus unknownNCT04958278
• Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)Active, not recruitingNCT04956640Phase 1/2
• Patient-Reported Outcomes Among Women Wtih Gynecological Cancer (The CONNECT Study)CompletedNCT04945187Not applicable
• Social Interventions for Support During Treatment for Endometrial Cancer and RecurrenceActive, not recruitingNCT04930159Not applicable
• Study of XB002 in Subjects With Solid Tumors (JEWEL-101)CompletedNCT04925284Phase 1
• The Compatibility of Preoperative Endometrial Biopsies With Postoperative Final Pathology in Endometrial CancerCompletedNCT04917341
• Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial CancerTerminatedNCT04906382Early Phase 1
• Complications of Laparoscopic Hysterectomy and Sentinel Lymph Node Biopsy for Endometrial CarcinomaStatus unknownNCT04894552Not applicable

← Endometrial Neoplasms overview